Search Results 381-390 of 16437 for monoclonal antibody

  1. Hematology - Clinical trials

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  2. Colon Cancer Clinical Trials

    Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. It is not yet known whether giving combination ...

  3. Three new high-tech tools for state scientists from Minnesota Partnership - Mayo Clinic News Network

    D., Mayo Clinic; Claudia Neuhauser, Ph.D., University of Minnesota. Antibody phage display for monoclonal antibodies. Antibodies are identified and used not ...

  4. Pseudomembranous colitis - Diagnosis & treatment - Mayo Clinic

    The U.S. Food and Drug Administration (FDA) has approved the use of the human monoclonal antibody bezlotoxumab to reduce the risk of recurrence of C.

  5. Tislelizumab-jsgr (intravenous route) - Mayo Clinic

    Tislelizumab-jsgr is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by ...

  6. Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells. Biological therapies, such as brentuximab ...

  7. Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer - Mayo Clinic

    Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.

  8. Study of Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder - Mayo Clinic

    Monoclonal antibodies, such as rituximab may block tumor growth in different ways by targeting certain cells. LMP-specific T-cells are special immune system ...

  9. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

    Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  10. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab and bevacizumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy ...